These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19385345)

  • 1. [Update on current care guidelines. Safe use of non-steroidal anti-inflammatory drugs].
    Karvonen AL; Hakala M; Helin-Salmivaara A; Kankaanranta H; Kivilaakso E; Kunnamo I; Lehtola J; Martio J
    Duodecim; 2009; 125(5):563-4. PubMed ID: 19385345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment and prophylaxis of alimentary tract lesions caused by non-steroid anti-inflammatory drugs].
    Gil J; Wojtuń S
    Pol Merkur Lekarski; 2009 May; 26(155):353-7. PubMed ID: 19606672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
    Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?
    Barozzi N; Tett SE
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK.
    Suh DC; Hunsche E; Shin HC; Mavros P
    Rheumatology (Oxford); 2008 Apr; 47(4):458-63. PubMed ID: 18263598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAIDs, musculoskeletal disorders and gastrointestinal adverse effects.
    Day R; Seideman P
    Aust Fam Physician; 1991 Dec; 20(12):1735-7. PubMed ID: 1805775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic musculoskeletal pain in the elderly: opinions on oral medication use.
    Kean WF; Rainsford KD; Kean IR
    Inflammopharmacology; 2008 Apr; 16(2):53-75. PubMed ID: 18389178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain management. Medication update.
    Slagle MA
    South Med J; 2001 Aug; 94(8):771-4. PubMed ID: 11549190
    [No Abstract]   [Full Text] [Related]  

  • 12. Sociodemographic factors influence use of proton pump inhibitors among users of nonsteroidal anti-inflammatory drugs.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):855-61. PubMed ID: 19465157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concomitant use of warfarin, analgesics and anti-inflammatory agents].
    Håkonsen GD; Pettersen MH; Skurtveit S; Giverhaug T
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1217-20. PubMed ID: 19521444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
    Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
    Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complication of NSAIDs treatment in gastrointestinal tract].
    Wojtuń S; Gil J; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2004; 17 Suppl 1():133-5. PubMed ID: 15603371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
    Rostom A; Moayyedi P; Hunt R;
    Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis.
    Inotai A; Mészáros A
    Int J Technol Assess Health Care; 2009 Apr; 25(2):190-5. PubMed ID: 19366498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and risk of upper gastrointestinal bleeding in NSAID users.
    Ibáñez L; Vidal X; Laporte JR
    Am J Gastroenterol; 2008 Oct; 103(10):2658-9. PubMed ID: 18855866
    [No Abstract]   [Full Text] [Related]  

  • 19. Protecting the stomach from the "toxins" of NSAIDS and anti-platelet agents.
    Echelmeyer S; Kanwal F
    Mo Med; 2009; 106(5):343-5. PubMed ID: 19902714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of medication in low back pain.
    Mens JM
    Best Pract Res Clin Rheumatol; 2005 Aug; 19(4):609-21. PubMed ID: 15949779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.